Very interesting news
-
-
I saw that too
I did some digging around, not a lot of new info out there yet but I did find this.
-
A bit more illumination on this dark horse:
The company site
Speculative article at Genomes Unzipped
They're scheduled for a talk at AGBT on Saturday (the shiny new toy session). Rack based set-up, real time tweakability.
Sequence until... Sufficient. I love it!Comment
-
Agbt
Hello - saw your post and thank you. Oxford Nanopore isn't actually on the agenda at this year's AGBT. There are talks through from our academic collaborators about the nanopore research being conducted in their labs, which we hope you will find of interest. Enjoy AGBT!Comment
-
Well huh.
Given the founder of the company is talking and what session it's in I thought there might be something exciting going on... Definitely looking forward to it, anyways.Comment
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM
Comment